Skip to Content

Cipla Ltd ADR CPLFY

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

There is no Morningtar’s Analysis data available.

Company Profile

Business Description

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large global presence. Cipla's growth strategy focuses on new product launches.

Contact
Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park
Mumbai, MH, 400 013, India
T +91 2224826000
Sector Healthcare
Industry Drug Manufacturers - General
Most Recent Earnings Jun 30, 2021
Fiscal Year End Mar 31, 2022
Stock Type
Employees 21,565